Condensed Consolidated Statements of Operations (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Net Revenues:
Patient services	$ 21,724,423	$ 8,747,414	$ 56,211,160	$ 23,962,216
Management fees from affiliates	1,460,163	1,880,610	4,986,012	5,951,165
Equity in earnings of affiliates	1,448,898	1,637,354	4,502,759	4,833,992
Other revenue	1,048,381	171,804	3,845,254	1,169,884
Provision for doubtful accounts	(682,319)	(123,413)	(2,409,733)	(386,165)
Revenue	24,999,546	12,313,769	67,135,452	35,531,092
Operating Expenses:
Salaries and benefits	6,974,734	3,472,076	19,770,112	10,246,078
Supplies	6,659,330	2,201,344	16,993,555	6,836,004
Other operating expenses	8,609,650	4,330,938	24,513,007	11,325,500
Impairment of goodwill	20,847,608		20,847,608
Depreciation and amortization	1,290,779	565,675	3,636,840	1,709,612
Total operating expenses	44,382,101	10,570,033	85,761,122	30,117,194
Other Income (Expense):
Interest expense, net	(552,763)	(285,844)	(1,575,535)	(840,602)
Gain (loss) on sale of equity investments in affiliates		83,533		365,111
Other income	36,694		39,852
Net other (expense)	(516,069)	(202,311)	(1,535,683)	(475,491)
Income (loss) from continuing operations, before taxes	(19,898,624)	1,541,425	(20,161,353)	4,938,407
Provision for income taxes	961,105		961,105
Income (loss) from continuing operations, net of taxes	(20,859,729)	1,541,425	(21,122,458)	4,938,407
Loss from discontinued operations, net of tax	(196,705)		(196,705)
Extraordinary gain, net of tax, attributable to Graymark Healthcare	4,872,746		4,872,746
Extraordinary gain, net of tax, attributable to noncontrolling interests	2,094,856		2,094,856
Net income (loss)	(14,088,832)	1,541,425	(14,351,561)	4,938,407
Less: Net income attributable to noncontrolling interests	2,402,532	384,257	1,522,445	452,157
Net income (loss) attributable to Graymark Healthcare	(16,491,364)	1,157,168	(15,874,006)	4,486,250
Earnings per common share (basic and diluted):
Net income (loss) attributable to Graymark Healthcare from continuing operations	$ (0.14)	$ 0.01	$ (0.14)	$ 0.03
Loss from discontinued operations, net of tax
Basic and diluted net income (loss) per share	$ (0.10)	$ 0.01	$ (0.10)	$ 0.03
Weighted average number of common and diluted shares outstanding	162,703,399	162,523,276	162,703,399	162,523,276
Pro Forma [Member]
Other Income (Expense):
Provision for income taxes	(1,008,978)	(616,570)	(1,240,455)	(1,975,363)
Less: Net income attributable to noncontrolling interests	2,401,087	230,554	1,170,410	271,294
Net income (loss) attributable to Graymark Healthcare	$ (16,537,792)	$ 694,301	$ (15,801,321)	$ 2,691,750
Earnings per common share (basic and diluted):
Basic and diluted net income (loss) per share	$ (0.10)		$ (0.10)	$ 0.02
Graymark Healthcare
Earnings per common share (basic and diluted):
Extraordinary gain, net of tax	$ 0.03		$ 0.03
Noncontrolling interests
Earnings per common share (basic and diluted):
Extraordinary gain, net of tax	$ 0.01		$ 0.01